Body contouring treatments continue to grow exponentially in popularity, and Cynosure is adding to the excitement with the launch of LIPOcel®.
It’s estimated that the body contouring device market will be worth USD $4.5billion globally by 2025 proving that market demand for non-surgical options is surging. Cynosure is adding to its lineup of medical devices for aesthetic procedures and precision surgical applications with state-of-the-art technology that has been designed and manufactured to the highest global standards.
LIPOCel® is a non-invasive, non-surgical body contouring treatment that uses high-intensity focused ultrasound (HIFU) to destroy fat cells without damaging peripheral tissue. It’s designed for focal fat reduction and precision body contouring in areas that are hard to change through diet, exercise and lifestyle alone including the flanks, stomach, arms, knees and back of thighs.
One of LIPOCel®’s biggest perks is its various cartridge depth options that make treating different parts of the body efficient and effective. The chill cartridge also ensures a comfortable treatment cooling the skin to 5 degrees and removing the need to apply numbing. Not only do patients receive a better experience, it also means treatment zones can be completed in 30 mins.
Of course, no downtime is an important deciding factor for patients and thanks to LIPOCel®’s ability to penetrate to 1.3cm within the fat layer, the epidermis goes unchanged and patients are able to resume their daily activities.
For practitioners, minimal running costs makes LIPOCel® an attractive option with six months of unlimited cartridge utilisation an effective way to maximise profits.
This article was sponsored by Cynosure
DID YOU KNOW
There are 5 ways you can catch up with SPA+CLINIC?
- Our quarterly print magazine, delivered to your door. Subscribe here.
- Our website, which is updated daily with its own completely unique content and breaking news.
- Our weekly newsletter – free to your inbox! Subscribe here.
- Our digital magazine – click here to view previous issues.
- Our social media – see daily updates on our Instagram, Facebook & Linkedin